NCT06896591

Brief Summary

This study aims to evaluate the effectiveness of a posterior hip capsule block performed in addition to a PENG (Pericapsular Nerve Group) block for patients undergoing hip arthroplasty. The primary objective is to assess whether this combined approach provides enhanced perioperative analgesia compared to the standard analgesic protocol or the PENG block alone. Secondary outcomes will focus on opioid consumption, functional recovery, and any potential complications. By targeting both the anterior and posterior innervation pathways around the hip joint, this combined technique could improve patient comfort, decrease opioid requirements, and potentially expedite rehabilitation after hip arthroplasty.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 26, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

March 26, 2025

Status Verified

March 1, 2025

Enrollment Period

8 months

First QC Date

March 13, 2025

Last Update Submit

March 19, 2025

Conditions

Keywords

total hip arthroplastypeng blockHipAnatomySciatic nerve block

Outcome Measures

Primary Outcomes (1)

  • Sciatic nerve block

    number of patients with postoperative sciatic motor or sensitory nerve block collected by clinical examination (test with hot and cold in the sciatic territory and motricity of the feet)

    From enrollment to the end of treatment at 1 month

Secondary Outcomes (5)

  • Pain postoperative

    From enrollment to the end of treatment at 1 MONTH

  • pain 2

    From enrollment to the end of treatment at 1 MONTH

  • oPIOID Consumption

    From enrollment to the end of treatment at 7 months

  • RAAC

    From enrollment to the end of treatment at 1 MONTH

  • Surgical complication

    From enrollment to the end of treatment at 1 MONTH

Study Arms (1)

DPPG compartment block

EXPERIMENTAL

Deep posterior post gluteal compartment block with different volume of product 5,10 and 15 ml (local anesthetics such as naropeine 0.35%) to compare the efficiency of the block without sciatic nerve block effect

Procedure: Deep posterior post gluteal nerve block

Interventions

One injection with ultrasound guidance injection of 5, 10 or 15 mL of naropeine 0.35 % Procedure : injection below the piriformis muscle in front of the head of the femur.

DPPG compartment block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All adults with total hip arthroplasty

You may not qualify if:

  • Contraindication to regional anesthesia
  • allergy
  • refusal of the injection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Pun M, Ng T, Vermeylen K, Tran J. Innervation of the hip joint: implications for regional anaesthesia and image-guided interventional pain procedures. BJA Educ. 2024 Jun;24(6):191-202. doi: 10.1016/j.bjae.2024.02.005. Epub 2024 Apr 8. No abstract available.

    PMID: 38764441BACKGROUND

Study Officials

  • yoann ELMALEH, M.D

    Hopital Privé Claude Galien

    PRINCIPAL INVESTIGATOR

Central Study Contacts

YOANN ELMALEH, M.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
NETWORK
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor, Anesthesiology and Pain Medicine, Principal Investigator

Study Record Dates

First Submitted

March 13, 2025

First Posted

March 26, 2025

Study Start

June 1, 2025

Primary Completion

February 1, 2026

Study Completion

March 1, 2026

Last Updated

March 26, 2025

Record last verified: 2025-03